Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$4.76 - $6.24 $1.94 Million - $2.54 Million
-407,291 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.7 - $9.1 $196,365 - $313,495
34,450 Added 9.24%
407,291 $2.44 Million
Q3 2021

Nov 12, 2021

BUY
$6.74 - $8.02 $234,241 - $278,727
34,754 Added 10.28%
372,841 $2.51 Million
Q2 2021

Aug 13, 2021

BUY
$7.6 - $10.28 $451,979 - $611,361
59,471 Added 21.35%
338,087 $2.72 Million
Q1 2021

May 17, 2021

BUY
$9.81 - $13.88 $2.73 Million - $3.87 Million
278,616 New
278,616 $2.79 Million

Others Institutions Holding NXTC

About NextCure, Inc.


  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $26.9M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.